Alkermes Plc (ALKS)

NASDAQ
32.13
+0.05(+0.16%)
After Hours
32.13
-0.02(-0.06%)
- Real-time Data
  • Volume:
    1,159,154
  • Bid/Ask:
    29.30/33.39
  • Day's Range:
    31.77 - 32.53

ALKS Overview

Prev. Close
32.08
Day's Range
31.77-32.53
Revenue
1.1B
Open
31.99
52 wk Range
15.35-32.53
EPS
-0.39
Volume
1,159,154
Market Cap
5.18B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,446,600
P/E Ratio
-
Beta
0.96
1-Year Change
91.64%
Shares Outstanding
161,331,522
Next Earnings Date
Oct 27, 2021
What is your sentiment on Alkermes Plc?
or
Market is currently closed. Voting is open during market hours.

Alkermes Plc News

Alkermes Plc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Buy
SummaryStrong SellStrong SellStrong BuyStrong BuyStrong Buy

Alkermes Plc Company Profile

Alkermes Plc Company Profile

Employees
2245

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.

Read More
  • Why again going down ??
    0
    • No reason to go up for next 3 months. Buy at 19 -19.10..stay long
      0
  • Why again getting into sh... somebody there?
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.